Importance of Regulations for Advertising Medicines and Medical Devices
Healthcare regulations safeguard public health by ensuring accurate information and ethical
marketing. They prevent misleading claims, promote responsible advertising, and require
scientific evidence for product claims. This empowers patients with reliable information and
protects them from misuse of medications. Regulations also ensure fair competition within the
industry.
1. Which laws apply when it comes to promoting medicines and medical devices?
1.1 Medicines
- Therapeutic Products Act (TPA)
- Ordinance on Advertising for Medicinal Products (OAMP)
- Ordinance on Integrity and Transparency in the context of Therapeutic Products (OITTP)
- Unfair Competition Act (UCA)
- Swiss Criminal Code (anti-bribery provisions)
1.2 Medical Devices
- Therapeutic Products Act (TPA)
- Medical Devices Ordinance (MedDO)
- Unfair Competition Act (UCA)
- Swiss Criminal Code (anti-bribery provisions)
2. Are there any additional legislative frameworks, such as self-regulatory codes of conduct, that control the advertising of pharmaceuticals and medical devices?
2.1 Medicines
- Pharma Code: Code of Conduct of the Pharmaceutical Industry in Switzerland
-
Pharma Cooperation Code: Code on cooperation with Healthcare Professional Circles and Patient
Organizations
2.2 Medical Devices
- Swiss Medtech Code of Ethical Business Practice
3. What licenses, approvals, or fees are required for advertising medications and medical devices to the general public and healthcare professionals?
3.1 General Public
Medicines: Public advertising for certain medicines (e.g., analgesics, sleeping drugs,
sedatives, laxatives, and appetite suppressants) must be approved by Swissmedic. Repeat
infringers may need pre-approval for all advertising materials.
3.2 Healthcare Professionals
Medicines: No licenses or approvals are required for professional promotion.
4. Does Swiss law govern the advertisement of prescription and over-the-counter medications differently?
- Prescription-Only Medicines: Advertising to the general public is prohibited.
- Over-the-Counter (OTC) Medicines: Advertising is permitted with restrictions.
5. What are the primary limits on promoting drugs and medical devices to the public?
5.1 Medicines
Lawfulness: Advertising is unlawful if misleading or contrary to public order
and morality. Claims must be substantiated with reliable scientific evidence and align with
Swissmedic-approved professional information.
Marketing Authorization: Medicines may only be advertised after receiving
authorization from Swissmedic or a cantonal authority, including for new uses, dosages, or
forms.
Prohibitions:
- Encouraging excessive or inappropriate use
- Disguised or intrusive advertising not clearly identifiable as advertising
-
Direct sales promotion through free samples or vouchers; sample packs must be marked “free
sample” and limited to a daily dose
OTC Medicines: Advertising must reflect the latest approved product information
without exaggeration. Only approved indications and uses may be promoted.
5.2 Medical Devices
- Advertising must reflect accurate product information
- Misleading statements regarding purpose, safety, or performance are prohibited
-
Devices intended solely for healthcare professionals must not be advertised to the general
public
6. What are the primary limits on promoting drugs and medical devices to healthcare professionals?
6.1 Medicines
- Advertising must not be misleading
- Claims must be supported by evidence
- Information must reflect the current state of scientific knowledge
- Adverse reactions must be accurately represented
6.2 Medical Devices
- Advertising must not be misleading
- Claims must correspond to approved product information
7. What is the required information for advertisements directed only at healthcare professionals?
7.1 Medicines
- Brand name
- Active ingredient(s)
- Marketing authorisation holder’s name and address
- At least one indication or use, dosage, and method of administration
- Restrictions, adverse reactions, and interactions
- Product category
- Reference to detailed product information
- Withdrawal periods for veterinary medicines
7.2 Medical Devices
No specific legal provisions define mandatory content requirements.
8. What information must be included in public-facing advertisements for drugs and medical devices?
8.1 Medicines
- Brand name
- Marketing authorisation holder’s name
- At least one indication or use
-
Indication that the product is authorised and that the package leaflet should be read
- Withdrawal periods for veterinary medicines
8.2 Medical Devices
No specific legal provisions define mandatory content requirements.
9. Are there any constraints on the data used to support promotional claims?
9.1 Medicines
Prescription Medicines:
- Advertising must reflect the latest scientific knowledge
-
Claims must reference clinical trials or data collections published or accepted for
publication
- Good Clinical Practice guidelines must be followed
- References must be quoted verbatim and fully cited
OTC Medicines:
-
Advertising must not reference scientific publications, clinical studies, or endorsements
-
Endorsements by experts, healthcare professionals, celebrities, or laypersons are prohibited
9.2 Medical Devices
Advertising claims must align with the device’s clinical evaluation or testing results.
10. Are there any rules governing comparative advertising of drugs and medical devices?
10.1 Medicines
Professional Promotion:
Comparisons are permitted if scientifically accurate and based on equivalent clinical trials
or data collections in accordance with Art. 7 and Art. 5(5) OAMP.
Promotion to the General Public:
Comparative advertising is permitted under Art. 22(c) OAMP but must not suggest equivalence or
superiority over other medicines or treatments.
10.2 Medical Devices
The MedDO contains no specific comparative advertising rules. Comparisons must be accurate and
fair in line with Art. 3(e) UCA.
11. Are there special guidelines for advertising drugs and medical devices on the internet or social media?
11.1 Medicines
Promotion to the General Public:
-
Advertising of category C and D medicines on electronic media must include a special note
confirming authorisation and advising consultation or reading package information
- Specific design and font size requirements apply (Art. 17 OAMP)
-
Advertising for analgesics, sleeping drugs, sedatives, laxatives, and appetite suppressants
mentioning abuse or dependence must be approved by Swissmedic (Art. 23(1) OAMP)
Professional Promotion:
-
Advertising to healthcare professionals must not be publicly accessible online
-
Access must be restricted by appropriate technical and password protections (Art. 5a OAMP)
11.2 Medical Devices
No specific internet advertising regulations apply. General advertising rules must be followed.
12. Which bodies oversee compliance and what are the legal ramifications for noncompliance?
Administrative Measures
Under the Therapeutic Products Act (TPA), Swissmedic and the Federal Office of Public Health may
impose administrative measures.
- Confiscation and Storage: Inadmissible advertising materials may be seized,
stored, or destroyed
- Prohibition of Advertising: Temporary or permanent bans may be imposed and
publicly announced at the offender’s expense
- Pre-approval Requirement: Repeat offenders may be required to submit all
advertising for prior approval
Administrative Criminal Measures
-
The Federal Office of Public Health prosecutes violations related to inducements
-
Violations may result in custodial sentences of up to three years or monetary fines
13. Are there any future developments in Switzerland?
In 2025, the Ordinance on Integrity and Transparency will be amended to cover medical devices,
not only prescription medicines, with potential exemptions for certain device categories.
How can OMC help?
- Professional review of marketing and advertising materials with reports
- Services to obtain authority approvals where required
-
Translation of marketing materials by a professional translation agency certified with ISO
17100